Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Steven O’Day et al.|Clinical Cancer Research|2023Cited by 27
Data from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Steven O’Day et al.|Unknown|2023Cited by 1
Supplementary Data 1 from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Steven O’Day et al.|Unknown|2023Cited by 0
Supplementary Data 3 from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Steven O’Day et al.|Unknown|2023Cited by 0
Supplementary Data 2 from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I TrialEspen B. Ellingsen, Yousef Zakharia, Steven O’Day et al.|Unknown|2023Cited by 0